Navigation Links
Pro-Dex, Inc. Appoints Harold A. Hurwitz as Chief Financial Officer
Date:10/6/2010

IRVINE, Calif., Oct. 6 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) today announced the appointment of Harold A. ("Hal") Hurwitz as Chief Financial Officer, effective October 6, 2010.  Mr. Hurwitz succeeds Jeffrey J. Ritchey who has left the Company.

"Hal comes to Pro-Dex with a broad financial background that includes Big 4 public accounting experience as a Partner with Coopers & Lybrand LLP, now part of PricewaterhouseCoopers LLP, as well as public and private company financial management responsibility," commented Mark Murphy, Pro-Dex's Chief Executive Officer.  "We are delighted to have Hal on our team to help accomplish the goals we have established."  Commenting on Mr. Ritchey, Mr. Murphy continued, "On behalf of the entire Board of Directors, I want to thank Jeff for his dedication to Pro-Dex over the last nine years.  We greatly appreciate the contributions he has made, particularly in having served the company in multiple capacities during its development.  We wish him well in his future endeavors."

"I am privileged to be joining Pro-Dex at this exciting time," said Mr. Hurwitz. "Pro-Dex's ability to strengthen itself even through the uncertainties of the recent economic environment is impressive, and I look forward to being part of the leadership team that continues to build upon these strengths to position the company for future growth."

Through February 2010, Mr. Hurwitz was Vice President and Chief Financial Officer for Interventional Spine Inc., a medical device company focused on percutaneous systems for treatment of back pain.  Prior to that, he was a Principal Consultant with McDermott & Bull, a retained executive search firm where he specialized in serving the life science industry.   From 1997 through 2004, Mr. Hurwitz was Vice President and Chief Financial Officer for Micro Therapeutics, Inc., a developer and manufacturer of interventional neurovascular medical devices.  Mr. Hurwitz began his career with Coopers & Lybrand LLP, where he served for 22 years, leading its life science and high technology practices in Orange County.  

Pro-Dex, Inc., with operations in California, Oregon and Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.  Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.  For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
3. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
4. PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement
5. Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimers Disease
6. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
7. 3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer
8. Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
9. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. Kinetic Systems Appoints Peter M. Maris President & Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... NEW YORK , February 27, 2017 ... that the global medical marijuana market alone is expected to reach ... Washington D.C. along with 28 states have legalized ... Arkansas , Florida , North ... Pennsylvania were approved to use the drug in medical ...
(Date:2/27/2017)... Netherlands , Feb 27, 2017 ... is approved by NATO for use at the security level ... imposed within the NATO organization for the communication of classified ... ... government authorities with an eavesdrop-secure smartphone solution. Sectra Tiger/R is ...
(Date:2/24/2017)... DUBLIN , Feb. 24, 2017 Research and ... Analysis & Trends - Industry Forecast to 2025" report to their ... The Global Empty ... over the next decade to reach approximately $2.9 billion by 2025. ... all the given segments on global as well as regional levels presented ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the ... studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society of ... Liegner, M.D. has compiled into a single volume a compelling argument that the disease ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... to announce an upgrade to the company's Yelp listing. Bay Area residents struggling ... as diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as ...
(Date:2/26/2017)... Dublin, Ireland (PRWEB) , ... February 26, 2017 ... ... accreditation, as in 2011 the lab became the world’s first to be ISO/IEC ... d 1 (cat allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have the ability to sharpen ... With ProSharpen Color users have total control over sharpening amount, sharpening radius, threshold, horizontal ... color spectrum tools users can visually see the color range effected with ease all ...
Breaking Medicine News(10 mins):